格隆汇3月6日丨前海健康(00911.HK)公布,集团预期录得股东应占溢利约130万港元,跟截至2023年12月31日止年度录得约5270万港元的亏损相比,实现转亏为盈。年度转亏为盈主要是由于以下各项的主要原因包括:(i)由上年度的毛损转为该年度的毛利,约2970万港元,乃由于集团策略性转向销售较高利润之产品组合;(ii)处置子公司获得约5190万港元的一次性收益;及(iii)抵销因电子元件产品的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.